TRANSCEPT PHARMACEUTICALS IN's ticker is TSPT and the CUSIP is 89354M106. A total of 46 filers reported holding TRANSCEPT PHARMACEUTICALS IN in Q2 2013. The put-call ratio across all filers is 1.87 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2013 | $105,000 | – | 21,869 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Roumell Asset Management, LLC | 2,167,361 | $7,282,000 | 7.73% |
| NEA Management Company, LLC | 2,086,755 | $7,011,000 | 0.34% |
| TOURADJI CAPITAL MANAGEMENT, LP | 10,000 | $34,000 | 0.13% |
| BVF INC/IL | 150,000 | $504,000 | 0.09% |
| SABBY MANAGEMENT, LLC | 281,330 | $945,000 | 0.06% |
| Central Square Management LLC | 19,000 | $64,000 | 0.05% |
| ABNER HERRMAN & BROCK LLC | 20,000 | $68,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 67,000 | $225,000 | 0.01% |
| Spark Investment Management LLC | 11,100 | $37,000 | 0.01% |
| COMMONWEALTH OF PENNSYLVANIA PUBLIC SCHOOL EMPLS RETRMT SYS | 52,000 | $175,000 | 0.00% |